Roger L. Flowerdew

Cognetix, Inc. discovered and developed drugs. Its products were used for the treatment of epilepsy, local anesthesia, heart disease, stroke, neuromuscular back pain, multiple sclerosis, and spinal cord injury. The company was founded in 1996 by Dennis B. Farrar, Baldomero M. Olivera and J. Michael McIntosh and was headquartered in Salt Lake City, UT

Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology

ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada.

Fuseforward International, Inc. develops asset, infrastructure and operations management solutions for asset-centric private and public-sector customers. The company was founded in 1998 and is headquartered in Vancouver, Canada.

Radient Technologies, Inc. engages in the extraction, purification, and isolation of naturally derived compounds and ingredients. It offers pharmaceutical intermediates from biomass for biotech/oncology companies; nutraceutical compounds from biomass for nutraceutical companies; and oil from spent biomass. Radient also offers its products based on its MAP technology that involves the selective and localized heating of the moisture present in various natural materials using microwaves. The company was founded by Steven Splinter in 2001 and is headquartered in Edmonton, Canada.